Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Apr 1, 2026 · Filed Apr 3, 2026
Houlihan Lokey's GENERAL COUNSEL sold $72K of Houlihan Lokey shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$71,700
Shares × reported transaction price
62 days after results of Jan 29, 2026, 36 days before results of May 7, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +10.9% | +4.1% | +6.7% |
| 30 days | +4.6% | +11.4% | −6.8% |
| 90 days | +1.2% | +14.0% | −12.8% |
| 180 days | −9.8% | +17.6% | −27.4% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
A board member of Houlihan Lokey sold $854K of Houlihan Lokey shares. Nobody planned it ahead of time.